GGrantIndex
Sort

51,593 grants matching hepatitis

The Effect of TCF7L2 on Glucose Metabolism

$488,753
Adrian Vella · Mayo Clinic Rochester · R01 · FY2014 · DK

BU Clinical HIV/AIDS Research Training Program (BU-CHART

$488,729
Benjamin P Linas · Boston Medical Center · T32 · FY2023 · AI

RBP2 Biology and Pathobiology

$488,672
William S Blaner · Columbia University Health Sciences · R01 · FY2020 · DK

Training Program in Substance Use, HIV and Related Infections

$488,616
Steffanie A Strathdee · University Of California, San Diego · T32 · FY2021 · DA

Role of HCV exosomes in intercellular communication

$488,538
Young S. Hahn · University Of Virginia · R01 · FY2022 · DK

MECHANISMS OF MURINE CORONAVIRUS NEUROVIRULENCE

$488,495
Scripps Research Institute · R01 · FY2003 · AI

Control of iron absorption by intestinal HIF2 in iron and hematological disorders

$488,462
Yatrik M Shah · University Of Michigan At Ann Arbor · R01 · FY2024 · DK

Phase I Clinical Translation Trial of Oncolytic rVSV-F Virotherapy for HCC

$488,385
Savio L Woo · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · CA

Role of lncRNA Meg3 in obesity-induced endothelial senescence and insulin resistance

$488,294
Xinghui Sun · University Of Nebraska Lincoln · R01 · FY2023 · HL

Regulation of glycogen in health and disease

$488,250
Alan R. Saltiel · University Of California, San Diego · R01 · FY2018 · DK

Pegylated Interferon +/- Ribavirin for Children with HCV

$488,250
Kathleen Schwarz · Johns Hopkins University · U01 · FY2006 · DK

Screening of Glycan Markers in Serum for Early Detection of HCC in Different Etiologies of Disease

$488,235
David M. Lubman · University Of Michigan At Ann Arbor · U01 · FY2019 · CA

Control of iron absorption by intestinal HIF2 in iron and hematological disorders

$488,225
Yatrik M Shah · University Of Michigan At Ann Arbor · R01 · FY2025 · DK

Social networks and HIV risk among rural drug users

$488,124
Jennifer R Havens · University Of Kentucky · R01 · FY2008 · DA

Alcohol & Antiretrovirals in HIV Infection, Oxidative Stress and Liver Disease

$488,095
Marianna K Baum · Florida International University · R01 · FY2009 · AA

Pathogenesis, prognosis, and treatment of NAFLD patients

$488,069
Anna Mae Elizabeth Diehl · Duke University · U01 · FY2007 · DK

See, Reach, Treat Tumor-Optimized Transarterial Chemoembolization Drug Delivery

$488,061
Jean-Francois H Geschwind · Johns Hopkins University · R01 · FY2014 · CA

Role of Transcription Coactivator OCA-B in Gene Poising and Immunological Memory

$488,056
Dean Tantin · University Of Utah · R01 · FY2022 · AI

Mechanisms of NAT2 Regulation of Insulin Resistance and Mitochondrial Dysfunction

$488,005
Joshua Wiley Knowles · Stanford University · R01 · FY2020 · DK

Novel Molecular Determinants of Insulin Clearance

$487,992
Miklos Peterfy · Western University Of Health Sciences · R01 · FY2022 · DK

Novel Approach to the Molecular Genetics of PKD1

$487,972
Johns Hopkins University · R37 · FY2005 · DK

Elucidating mechanisms of SIRT1 activation

$487,967
David A. Sinclair · Harvard Medical School · R01 · FY2020 · DK

Interferon regulation by NBR1-driven chaperone-mediated autophagy in stellate cells in liver cancer

$487,901
Jorge Moscat · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA

Expression, Regulation and Function of the SULT1C Carcinogen-Activating Enzymes

$487,888
Melissa A Runge-Morris · Wayne State University · R01 · FY2022 · ES

PICORNAVIRUS MOLECULAR BIOLOGY

$487,825
State University New York Stony Brook · R37 · FY2000 · AI